Edesa Biotech is trading 5% up at $5.00 in after-hours trading, with the move appearing primarily sector-driven amid biotech momentum and broader risk-on trading.
- It closed at $4.76 on September 2, 2026.
- No confirmed company-specific announcement was identified for September 2; its latest reported results were released August 13.
- Its next disclosed investor event is scheduled for September 12–13. Confidence is medium because no direct catalyst was confirmed.